Altered gut transcriptome in spondyloarthropathy

Annals of the Rheumatic Diseases

Volumn 65, Issue 10, 2006, Pages 1293-1300

  Laukens, D ^a,b   Peeters, H ^c   Cruyssen, B V ^c   Boonefaes, T ^b   Elewaut, D ^c   De Keyser, F ^c   Mielants, H ^c   Cuvelier, C ^c   Veys, E M ^c   Knecht, K ^d   Van Hummelen, P ^b   Remaut, E ^b   Steidler, L ^e   De Vos, M ^c   Rottiers, P ^b  

^a GHENT UNIVERSITY   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d Applied Maths BVBA ^*  (Belgium)

^e UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MESALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; STEROID; TRANSCRIPTOME;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; DIGESTIVE SYSTEM INFLAMMATION; DIGESTIVE SYSTEM INJURY; EXPRESSED SEQUENCE TAG; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC MARKER; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SPONDYLOARTHROPATHY; UNINDEXED SEQUENCE;

ADULT; AGED; BIOPSY; CHRONIC DISEASE; COLITIS; COLON; CROHN DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ILEITIS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SPONDYLARTHROPATHIES;

EID: 33750289548     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.047738     Document Type: Article

References (29)

1. Davis P, Thomson AB, Lentle BC. Quantitative sacroiliac scintigraphy in patients with Crohn's disease. Arthritis Rheum 1978;21:234-7.
2. Scott WW Jr, Fishman EK, Kuhlman JE, Caskey CI, O'Brien JJ, Walia GS, et al. Computed tomography evaluation of the sacroiliac joints in Crohn disease. Radiologic/clinical correlation. Skeletal Radiol 1990;19:207-10.
3. Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, et al. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 1995;22:2273-8.
4. De Vos M, Mielants H, Cuvelier C, Elewaut A, Veys E. Long-term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology 1996;110:1696-703.
5. Demetter P, Baeten D, De Keyser F, De Vos M, Van Damme N, Verbruggen G, et al. Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex. Ann Rheum Dis 2000;59:211-6.
6. Elewaut D, De Keyser F, Van Den Bosch F, Lazarovits AI, De Vos M, Cuvelier C, et al. Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis. J Rheumatol 1998;25:1932-7.
7. Demetter P, Van Huysse JA, De Keyser F, Van Damme N, Verbruggen G, Mielants H, et al. Increase in lymphoid follicles and leukocyte adhesion molecules emphasizes a role for the gut in spondyloarthropathy pathogenesis. J Pathol 2002;198:517-22.
8. Elewaut D, De Keyser F, Cuvelier C, Lazarovits Al, Mielants H, Verbruggen G, et al. Distinctive activated cellular subsets in colon from patients with Crohn's disease and ulcerative colitis. Scand J Gastroenterol 1998;33:743-8.
9. Baeten D, Demetter P, Cuvelier CA, Kruithof E, Van Damme N, De Vos M, et al. Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy. J Pathol 2002;196:343-50.
10. Bjarnason I, Helgason KO, Geirsson AJ, Sigthorsson G, Reynisdottir I, Gudbjartsson D, et al. Subclinical intestinal inflammation and sacroiliac changes in relatives of patients with ankylosing spondylitis. Gastroenterology 2003;125:1598-605.
11. Laukens D, Peeters H, Marichal D, Vander Cruyssen B, Mielants H, Elewaut D, et al. CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease. Ann Rheum Dis 2004;64:930-935.
12. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for me classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
13. Mielants H, Veys EM, De Vos M, Cuvelier C, Goemaere S, De Clercq L, et al. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. J Rheumatol 1995;22:2266-72.
14. Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, et al. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol 1995;22:2279-84.
15. De Vos M. Ileocolonoscopy in seronegative spondylarthropathy. Gastroenterology 1989;96:339-344.
16. Cuvelier C, Barbatis C, Mielants H, De Vos M, Roels H, Veys E. Histopathology of intestinal inflammation related to reactive arthritis. Gut 1987;28:394-401.
17. Puská LG, Zvara A, Hackler L Jr, Van Hummelen P. RNA amplification results in reproducible microarray data with slight ratio bias. Biotechniques 2002;32:1330-4, 1336, 1338, 1340.
18. Aimone-Gastin I, Cable S, Keller JM, Bigard MA, Champigneulle B, Gaucher P, et al. Studies on peroxisomes of colonic mucosa in Crohn's disease. Dig Dis Sci 1994;39:2177-85.
19. Beno I, Staruchova M, Volkovova K. Ulcerative colitis: activity of antioxidant enzymes of the colonic mucosa. Presse Med 1997;26:1474-7.
20. Tuzun A, Erdil A, Inal V, Aydin A, Bagci S, Yesilova Z, et al. Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 2002;35:569-72.
21. Lawrance IC, Fiocchi C, Chakravarti S. Ulcerative colitis and Crohn's disease: distinctive gene expression profiles and novel susceptibility candidate genes. Hum Mol Genet 2001;10:445-56.
22. Dooley TP, Curto EV, Reddy SP, Davis RL, Lambert GW, Wilborn TW, et al. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm Bowel Dis 2004;10:1-14.
23. Costello CM, Mah N, Hasler R, Rosenstiel P, Waetzig GH, Hahn A, et al. Dissection of the inflammatory bowel disease transcriptome using genomewide cDNA microarrays. PLoS Med 2005;2:e199.
24. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, Spielman RS, et al. Genetic analysis of genome-wide variation in human gene expression. Nature 2004;430:743-7.
25. Barmada MM, Brant SR, Nicolae DL, Achkar JP, Panhuysen CI, Bayless TM, et al. A genome scan in 260 inflammatory bowel disease-affected relative pairs. Inflamm Bowel Dis 2004;10:513-20.
26. van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM. Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 2004;13:763-70, Epub 2004 Feb 19.
27. Vermeire S, Rutgeerts P, Van Steen K, Joossens S, Claessens G, Pierik M, et al. Genome wide scan in a Flemish inflammatory bowel disease population: support for the IBD4 locus, population heterogeneity, and epistasis. Gut 2004;53:980-6.
28. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM, et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000;66:1863-70, Epub 2000 Apr 21.
29. Cho JH, Nicolae DL, Ramos R, Fields CT, Rabenau K, Corradino S, et al. Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease. Hum Mol Genet 2000;9:1425-32.